CU6 2.47% $6.72 clarity pharmaceuticals ltd

ASX: CU6 Outlook., page-2

  1. 244 Posts.
    lightbulb Created with Sketch. 35
    Perhaps a buying opportunity may present itself if the price dips further (either to average down or take a new position), because of the potential sell down when the shares get released from escrow on 29/09? I feel for the ipo holders given the slide from $1.50 and hope the company will produce the results to warrant a much higher share price. BP have a spec buy rating of $1.77 on the company. Good luck.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.